Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
20th Anniversary
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Decentralized Clinical Trials (DCTs)
Site Management (SMO)
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
About Tigermed
20th Anniversary
Gratitude, Achievement, Gathering, Sailing
Twenty years ago, a
few ambitious
entrepreneurs started their journey from a small room in a residential
building, using the colors of dreams to paint a story about Tigermed.
From Hangzhou and
Shanghai to the whole country and the globe, over 20 years, we have continued to grow,
expand our business footprint, and enhance our service capabilities, achieving milestone
after milestone.
We have built an integrated platform for clinical
development of innovative drugs and medical devices, enabling more than 100 innovative
medical products to successfully enter the market. Those shining dreams are becoming a
reality one by one.
We have established a comprehensive global layout, with tens of thousands of Tigermed people in more than ten countries around the world. Regardless of culture or race, we ensure seamless collaboration in global synchronized drug development, allowing medical progress to benefit humanity.
Behind every miracle of life, there is always relentless innovation.
Over the past 20
years, we have witnessed and participated in China's transition from generic drug
manufacturing to innovation. We have also driven the shift from traditional to digital
clinical trials, adding rich hues to innovation.
2012
A share
Twenty years of growth have been tinted with
honor, and twenty years of development have carved out a monument for Tigermed. In 2012,
Tigermed successfully listed on the Shenzhen Stock Exchange ChiNext Market, becoming the
first clinical CRO company to go public in China. In 2020, we successfully listed on Hong
Kong's main board, becoming a dual-listed company in A+H shares.
2020
H share
Behind these brilliant achievements lie
long-term trust from customers, partners, and the industry, as well as the continuous
efforts of outstanding Tigermed people over 20 years.
Serving innovation, building health together. Always
walking hand in hand with innovation. This is the most beautiful color of Tigermed, painted with time.
It is also the most beautiful story of time for all Tigermed people.
Management Comments
Entrepreneurship is
arduous and always requires pioneering efforts; innovation is not easy, but its achievements are
remarkable. Along the way, we are grateful to all our customers, investors and partners for their
long-term trust and to all our employees for their tireless efforts. We are also thankful for an era
in which the pharmaceutical industry continues to evolve and the value of innovation is recognized
as never before. After 20 years, we have embarked on a new journey. Tigermed will continue to
innovate with all of you and work hand in hand with our global partners to bring the benefits of
pharmaceutical innovation to human health! 20 years on, Tigermed is grateful to have traveled this
road with you!
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.